Cite
HARVARD Citation
Remon, J. et al. (2018). Corrigendum to "Immune-checkpoint inhibition in first-line treatment of advanced non-small cell lung cancer patients: Current status and future approaches" [Lung Cancer 106 (2017) 70–75]. Lung cancer. pp. 80-. [Online].